These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18296856)

  • 1. Coronary artery bypass grafting following in-stent restenosis of drug-eluting stents deployed in the left main coronary artery.
    Kanemitsu S; Tanaka K; Tanaka J; Suzuki H; Kinoshita T
    Circ J; 2008 Mar; 72(3):502-4. PubMed ID: 18296856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of coronary artery bypass grafting following implantation of a paclitaxel-eluting or a bare-metal stent into a single coronary artery.
    Martin JL; Ellis SG; Colombo A; Grube E; Maloney T; Friedman MI; Baim DS; Dawkins K; Caputo R; Stone GW
    Am J Cardiol; 2009 Jan; 103(1):11-6. PubMed ID: 19101222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of percutaneous coronary intervention (with drug-eluting stents) versus coronary artery bypass grafting in women with severe narrowing of the left main coronary artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry).
    Buchanan GL; Chieffo A; Meliga E; Mehran R; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Narbute I; Makkar RR; Palacios IF; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Allgar V; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    Am J Cardiol; 2014 Apr; 113(8):1348-55. PubMed ID: 24581924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-eluting stents restenosis 2 months after the procedure and necessitating semi-emergency off-pump coronary artery bypass].
    Iwakura T; nomoto S; Yamamoto K; Fujita T; Ohira N; Sakamoto T; Okamura H
    Kyobu Geka; 2006 May; 59(5):369-72. PubMed ID: 16715886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-pump coronary endarterectomy with stent removal for in-stent restenosis in the left anterior descending artery.
    Nishigawa K; Fukui T; Takanashi S
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):594-7. PubMed ID: 26273070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
    Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Comparison of Clinical Outcomes After Drug-Eluting Balloon and Drug-Eluting Stent Use for Left Main Bifurcation In-Stent Restenosis.
    Lee WC; Hsueh SK; Chen CJ; Yang CH; Fang CY; Wu CJ; Fang HY
    Int Heart J; 2018 Sep; 59(5):935-940. PubMed ID: 30101849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
    Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K
    Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid Strategy to Treat Life-Threatening Giant Coronary Artery Aneurysm With Severe In-Stent Restenosis.
    Lee WC; Fang HY; Fang CY
    Int Heart J; 2017 Apr; 58(2):283-285. PubMed ID: 28321023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-stent restenosis in the left anterior descending coronary artery: what is the solution for diffuse disease? Patch reconstruction and coronary artery bypass grafting-surgery as the first option in complex coronary artery disease.
    Barbato L; Grasso MA; Spagnolo S
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1238. PubMed ID: 30445436
    [No Abstract]   [Full Text] [Related]  

  • 14. In-stent restenosis: surgical and histopathological perspective.
    Srimurugan B; Sigler M; Sankar NM; Cherian KM
    Asian Cardiovasc Thorac Ann; 2018 Feb; 26(2):114-119. PubMed ID: 29357687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
    Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
    J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological heterogeneity of in-stent restenosis in four coronary endarterectomy specimens.
    Takashima A; Shimabukuro M; Tabata M; Fukuda D; Uematsu E; Ishibashi-Ueda H; Takanashi S; Sata M
    Cardiovasc Pathol; 2015; 24(3):194-7. PubMed ID: 25483741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid coronary revascularization in the era of drug-eluting stents.
    Murphy GJ; Bryan AJ; Angelini GD
    Ann Thorac Surg; 2004 Nov; 78(5):1861-7. PubMed ID: 15511503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcomes of patients with percutaneous coronary intervention for unprotected left main coronary artery disease: a Hong Kong experience.
    Lo KY; Chan CK
    Hong Kong Med J; 2014 Jun; 20(3):187-93. PubMed ID: 24812198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.